These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24898040)

  • 1. Personalized pharmacogenomics: predicting efficacy and adverse drug reactions.
    Pirmohamed M
    Annu Rev Genomics Hum Genet; 2014; 15():349-70. PubMed ID: 24898040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic Markers of Drug Efficacy and Toxicity.
    Yip VL; Hawcutt DB; Pirmohamed M
    Clin Pharmacol Ther; 2015 Jul; 98(1):61-70. PubMed ID: 25870137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report on the pharmacogenomics and personalized medicine 2011 conference: part 1.
    Harrison N
    Pharmacogenomics; 2012 Jan; 13(2):141-5. PubMed ID: 22256866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
    La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
    Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
    Ross CJ; Visscher H; Sistonen J; Brunham LR; Pussegoda K; Loo TT; Rieder MJ; Koren G; Carleton BC; Hayden MR;
    Thyroid; 2010 Jul; 20(7):681-7. PubMed ID: 20578893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Medicine: Pharmacogenomics and Drug Development.
    Mirsadeghi S; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):150-165. PubMed ID: 28282716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of pharmacogenetics in the treatment of migraine.
    Borro M; Guglielmetti M; Simmaco M; Martelletti P; Gentile G
    Pharmacogenomics; 2019 Nov; 20(16):1159-1173. PubMed ID: 31637960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-genome sequencing in pharmacogenetics.
    Urban TJ
    Pharmacogenomics; 2013 Mar; 14(4):345-8. PubMed ID: 23438878
    [No Abstract]   [Full Text] [Related]  

  • 10. Opportunities and Challenges in Cardiovascular Pharmacogenomics: From Discovery to Implementation.
    Roden DM; Van Driest SL; Wells QS; Mosley JD; Denny JC; Peterson JF
    Circ Res; 2018 Apr; 122(9):1176-1190. PubMed ID: 29700066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
    Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
    Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly personalized reports for personalized drug selection by expert systems as clinical decision support.
    Hizel HC
    Per Med; 2017 Mar; 14(2):93-97. PubMed ID: 29754552
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenetics and pharmacogenomics: development, science, and translation.
    Weinshilboum RM; Wang L
    Annu Rev Genomics Hum Genet; 2006; 7():223-45. PubMed ID: 16948615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Therapeutics and Pharmacogenomics: Integral to Personalized Health Care.
    Sadee W
    Pharm Res; 2017 Aug; 34(8):1535-1538. PubMed ID: 28493098
    [No Abstract]   [Full Text] [Related]  

  • 16. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenomics: precision tool in routine prescription].
    Yu B
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Nov; 22(11):1143-1148. PubMed ID: 33172545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
    Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
    OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic biomarkers for personalized medicine.
    Chen JJ; Lin WJ; Chen HC
    Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic content of commercial genome-wide genotyping arrays.
    Lemieux Perreault LP; Zaïd N; Cameron M; Mongrain I; Dubé MP
    Pharmacogenomics; 2018 Oct; 19(15):1159-1167. PubMed ID: 30272537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.